Austrália - inglês - Department of Health (Therapeutic Goods Administration)

homart pharmaceuticals pty ltd - calcium carbonate, quantity: 900 mg (equivalent: calcium, qty 360 mg); colecalciferol, quantity: 5 microgram - capsule, soft - excipient ingredients: yellow beeswax; white beeswax; titanium dioxide; glycerol; gelatin; purified water; lecithin; soya oil; d-alpha-tocopherol - maintain/support bone health ; aids/assists healthy bone development/growth/building ; maintain/support bone strength ; a diet deficient in calcium can lead to osteoporosis in later life. calcium may help prevent osteoporosis when dietary intake is inadequate ; vitamin d helps calcium absorption (or words of like intent) and a diet deficient in calcium can lead to osteoporosis in later life ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

pinewood laboratories ltd - calcium acetate - tablet - 500 milligram(s) - calcium; calcium acetate anhydrous

Malta - inglês - Medicines Authority

sanofi malta limited - calcium polystyrene sulfonate - powder for oral suspension - calcium polystyrene sulfonate 99.934 % (w/w) - mineral supplements

Malta - inglês - Medicines Authority

hospira uk limited - calcium folinate - solution for injection - calcium folinate 10 mg/ml - all other therapeutic products

Malta - inglês - Medicines Authority

hospira uk limited - calcium folinate - solution for injection - calcium folinate 10 mg/ml - all other therapeutic products

Malta - inglês - Medicines Authority

hospira uk limited - calcium folinate - solution for injection - calcium folinate 10 mg/ml - all other therapeutic products

Estados Unidos - inglês - NLM (National Library of Medicine)

bausch health us, llc - edetate calcium disodium (unii: 25ih6r4sgf) (edetic acid - unii:9g34hu7rv0) - edetate calcium disodium 200 mg in 1 ml - edetate calcium disodium is indicated for the reduction of blood levels and depot stores of lead in lead poisoning (acute and chronic) and lead encephalopathy, in both pediatric populations and adults. chelation therapy should not replace effective measures to eliminate or reduce further exposure to lead. edetate calcium disodium should not be given during periods of anuria, nor to patients with active renal disease or hepatitis.

Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

magnesium 97mg (4mmol)) chewable tablets (neoceuticals ltd - magnesium glycerophosphate - chewable tablet - 97.2mg

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - calcium folinate pentahydrate 10.8 mg/ml (as 12.71 mg/ml of calcium folinate pentahydrate, equivalent to 10 mg/ml folinic acid) - concentrate for injection - 100 mg/10ml - active: calcium folinate pentahydrate 10.8 mg/ml (as 12.71 mg/ml of calcium folinate pentahydrate, equivalent to 10 mg/ml folinic acid) excipient: hydrochloric acid nitrogen sodium chloride sodium hydroxide water for injection - as rescue therapy to reduce toxicity following high-dose methotrexate therapy. has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions overdosage of methotrexate and in impaired methotrexate elimination reducing the toxicity and circumventing the effect of folic acid antagonists

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - calcium folinate pentahydrate 10.8 mg/ml (as 12.71 mg/ml of calcium folinate pentahydrate, equivalent to 10 mg/ml folinic acid) - concentrate for injection - 1000 mg/100ml - active: calcium folinate pentahydrate 10.8 mg/ml (as 12.71 mg/ml of calcium folinate pentahydrate, equivalent to 10 mg/ml folinic acid) excipient: hydrochloric acid nitrogen sodium chloride sodium hydroxide water for injection - as rescue therapy to reduce toxicity following high-dose methotrexate therapy. has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions overdosage of methotrexate and in impaired methotrexate elimination reducing the toxicity and circumventing the effect of folic acid antagonists